Figure S10. PKC inhibitors-mediated inflammasome activation specifically discriminates FMF patients from HD and from patients suffering from unrelated inflammatory conditions. p17
Appendix Table S1 . Figure S1 . PKC inhibitors specifically trigger IL-1β release and a fast cell death in monocytes from FMF patients-genotypes indicated. Fig S1A, B , C correspond to Fig 1A, 1B , 1C of the main manuscript, except that they were expanded to present the genotype of each FMF patient. The indicated number corresponds to the patient number as indicated in Appendix  Table S1 . (D) Cell death was monitored in real time by measuring propidium iodide influx/fluorescence every 5 minutes.
Data information:
(A-C) Each dot represents the mean value from three technical replicates for one HD or patient. The bar represents the median ± interquartile range.
(D-left panels) Each point of the curve corresponds to the mean of a biological triplicate assessing cell death of one HD or one FMF patient.
(D-right panels) The bar represents the mean ±SD of a biological triplicate. Figure S3 . Controls for the immunofluorescence staining presented in Fig 2A-B of the main manuscript.
Figure S2. PKC inhibitors specifically trigger IL-1β release and cell death in monocytes from FMF patients.
Monocytes from one healthy donor (HD) were left untreated (left panels) or treated with LPS (3h, 100 ng/ml) plus 5 µM Nigericin for 90 min. Cells in the top panels were stained with primary antibody against ASC (and Alexa-488-coupled secondary antibody-green) and DAPI, while cells in the lower panels were stained only with the secondary antibody. Representative images are shown. Scale bar 10 µm. 3 with genotypes indicated) . Fig S4A-D correspond to Fig 3A-B , D-E of main manuscript, except that they were expanded to present the genotype of each FMF patient. The indicated number corresponds to the patient number as indicated in Appendix  Table S1 . . Analysis of IRF8-edited population is shown as a control. One example out of three independent assays is shown. (C) Ratio of indels preserving the ORF in 17 independent cell lines generated by CRISPR/Cas9 at the same time as PKN1/2edited U937 cells. TFAP4 is known as a lethal target (Boboila et al, 2018) and is highlighted in blue as a control. Through clonal selection PKN1 KO were obtained, while we failed to obtain PKN2 KO . Figure S8 . Validation of the anti-Phospho Pyrin antibody.
Figure S5. Colchicine blocks inflammasome activation in monocytes from FMF patients following PKC inhibitor treatment (related to Fig
3xFLAG-Pyrin was immunoprecipitated in the cell lines expressing the indicated Pyrin variants. Western blot analysis using anti-phosphoS242 Pyrin and anti-Flag was performed. Note that the two degradation products around 50 kDa are heavily phosphorylated on S242 in both WT and p.M694V-expressing cells while the phosphorylation is undetectable in p.S242R Pyrinexpressing cells. Pyrin level was assessed by Western blot analysis in U937 cells expressing the indicated variants. All the cell lines express similar GFP level as WT Pyrin-expressing cells suggesting that the increased degradation is resulting from the specific mutations.
Figure S10. PKC inhibitors-mediated inflammasome activation specifically discriminates FMF patients from HD and from patients suffering from unrelated inflammatory conditions.
(A-C) Values from FMF patients are identical as the ones presented in Fig. 1 . The figures were not merged for clarity issues. Table S2 . Numerical parameters associated with the ROC curves presented in Fig. 5 The threshold values are indicated in pg/mL -1 for IL-1 β, in arbitrary units for the Area Under the real time cell death kinetics curves (AUC RTCD ) and minutes for the time to reach 20% cell death ( 
